What’s in a name? The use of a product code in a clinical trial protocol fails to circumvent clinical trial prior art (T 1255/21)
13 Jun 2024
United Kingdom
1 min read
The use of product or sponsor codes in clinical trial related documents is common practice in the pharmaceutical space. However, such codes may not always be sufficient to disregard a publication as relevant prior art against patent claims.In recent decision T...
Read more
